Table 3.xls (5.5 kB)

Result comparison between 107 serum samples tested by the Luminex xMAP and Roche anti-NC ECLIA anti-SARS-CoV-2 serologic assays.

Name: Result comparison between 107 serum samples tested by the Luminex xMAP and Roche anti-NC ECLIA anti-SARS-CoV-2 serologic assays.
Published: 2021-05-28T17:40:08+00:00
License: https://creativecommons.org/licenses/by/4.0/
Keywords: SARS-CoV -2 antibody detection, multiplex flow immunoassay, specimen type, community seroprevalence rates, FDA, Roche Diagnostics Elecsys anti-SARS..., multivariate pattern recognition so..., Luminex xMAP DBS assay results, blood spots Background, SARS-CoV -2 serologic testing, CLIR, SARS-CoV -2, NC, EUA, Luminex xMAP SARS-CoV -2 Multi-Anti..., Luminex xMAP assay, serum, Luminex xMAP DBS, Euroimmun anti-SARS-CoV -2 IgG ELISA, RBD

dataset

posted on 2021-05-28, 17:40 authored by Coleman T. Turgeon, Karen A. Sanders, Piero Rinaldo, Dane Granger, Heather Hilgart, Dietrich Matern, Elitza S. Theel

Result comparison between 107 serum samples tested by the Luminex xMAP and Roche anti-NC ECLIA anti-SARS-CoV-2 serologic assays.

History

Usage metrics

Categories

Keywords

Licence

Exports